PURPOSE: Geriatric issues in cancer are becoming prominent. Depression is a significant concern for both the elderly and patients with cancer, yet identifying depression in these patients is difficult and often leads to under-recognition. We conducted a systematic review to determine which depression instruments are appropriate for use in geriatric patients with cancer. METHODS: We identified the most commonly used self-report depression instruments. We then used the criteria established in the US Food and Drug Administration Draft Guidance on Patient-Reported Outcome Measures to determine the extent of validation evidence of these measures in geriatric cancer populations. Finally, we determined which instruments captured depressive symptoms that are common among elderly patients with cancer. RESULTS: Eight measures were selected as the most commonly used instruments. These were the Beck Depression Inventory-II, Brief Symptom Inventory-18, Center for Epidemiologic Studies-Depression Scale, Geriatric Depression Scale-15, Hospital Anxiety and Depression Scale, Patient Health Questionnaire-9, Profile of Mood States-Short Form, and Zung Self-Rating Depression Scale. Many have been validated for use with geriatric adults and patients with cancer; however, data addressing content validity and responder definition were lacking. To date, there is no validation information for geriatric patients with cancer. Furthermore, symptom profile analysis revealed that these measures do not identify many symptoms signaling depression in geriatric patients with cancer. CONCLUSION: The validation evidence for use of common depression instruments in geriatric patients with cancer is lacking. This, and the possibility that these measures may not assess common depressive symptoms in geriatric patients with cancer, questions the adequacy of these scales in this population.
PURPOSE: Geriatric issues in cancer are becoming prominent. Depression is a significant concern for both the elderly and patients with cancer, yet identifying depression in these patients is difficult and often leads to under-recognition. We conducted a systematic review to determine which depression instruments are appropriate for use in geriatric patients with cancer. METHODS: We identified the most commonly used self-report depression instruments. We then used the criteria established in the US Food and Drug Administration Draft Guidance on Patient-Reported Outcome Measures to determine the extent of validation evidence of these measures in geriatric cancer populations. Finally, we determined which instruments captured depressive symptoms that are common among elderly patients with cancer. RESULTS: Eight measures were selected as the most commonly used instruments. These were the Beck Depression Inventory-II, Brief Symptom Inventory-18, Center for Epidemiologic Studies-Depression Scale, Geriatric Depression Scale-15, Hospital Anxiety and Depression Scale, Patient Health Questionnaire-9, Profile of Mood States-Short Form, and Zung Self-Rating Depression Scale. Many have been validated for use with geriatric adults and patients with cancer; however, data addressing content validity and responder definition were lacking. To date, there is no validation information for geriatric patients with cancer. Furthermore, symptom profile analysis revealed that these measures do not identify many symptoms signaling depression in geriatric patients with cancer. CONCLUSION: The validation evidence for use of common depression instruments in geriatric patients with cancer is lacking. This, and the possibility that these measures may not assess common depressive symptoms in geriatric patients with cancer, questions the adequacy of these scales in this population.
Authors: Jimmie C Holland; Barbara Andersen; William S Breitbart; Michele Dabrowski; Moreen M Dudley; Stewart Fleishman; Genevieve V Foley; Caryl Fulcher; Donna B Greenberg; Carl B Greiner; Rev George F Handzo; Paul B Jacobsen; Sara J Knight; Kate Learson; Michael H Levy; Sharon Manne; Randi McAllister-Black; Amy Peterman; Michelle B Riba; Neal E Slatkin; Alan Valentine; Michael A Zevon Journal: J Natl Compr Canc Netw Date: 2007-01 Impact factor: 11.908
Authors: Arti Hurria; Supriya Gupta; Marjorie Zauderer; Enid L Zuckerman; Harvey J Cohen; Hyman Muss; Miriam Rodin; Katherine S Panageas; Jimmie C Holland; Leonard Saltz; Mark G Kris; Ariela Noy; Jorge Gomez; Ann Jakubowski; Clifford Hudis; Alice B Kornblith Journal: Cancer Date: 2005-11-01 Impact factor: 6.860
Authors: Ying Guo; Dominique L Musselman; Amita K Manatunga; Natalie Gilles; Kathryn C Lawson; Maryfrances R Porter; J Stephen McDaniel; Charles B Nemeroff Journal: Psychosomatics Date: 2006 Sep-Oct Impact factor: 2.386
Authors: Jane Walker; Kirstine Postma; Gillian S McHugh; Robert Rush; Brian Coyle; Vanessa Strong; Michael Sharpe Journal: J Psychosom Res Date: 2007-07 Impact factor: 3.006
Authors: Jacqui Rodgers; Colin R Martin; Rachel C Morse; Kate Kendell; Mark Verrill Journal: Health Qual Life Outcomes Date: 2005-07-14 Impact factor: 3.186
Authors: C B Terwee; L D Roorda; H C W de Vet; J Dekker; R Westhovens; J van Leeuwen; D Cella; H Correia; B Arnold; B Perez; M Boers Journal: Qual Life Res Date: 2014-01-09 Impact factor: 4.147
Authors: Kristine L Kwekkeboom; Lauren Tostrud; Erin Costanzo; Christopher L Coe; Ronald C Serlin; Sandra E Ward; Yingzi Zhang Journal: J Pain Symptom Manage Date: 2018-01-31 Impact factor: 3.612
Authors: Heidi D Klepin; Janet A Tooze; Timothy S Pardee; Leslie R Ellis; Dmitriy Berenzon; Shannon L Mihalko; Suzanne C Danhauer; Arati V Rao; Tanya M Wildes; Jeff D Williamson; Bayard L Powell; Stephen B Kritchevsky Journal: J Am Geriatr Soc Date: 2016-09-14 Impact factor: 5.562
Authors: Rebecca M Saracino; Mark I Weinberger; Andrew J Roth; Arti Hurria; Christian J Nelson Journal: Psychooncology Date: 2016-05-16 Impact factor: 3.894
Authors: Talia R Weiss Wiesel; Christian J Nelson; William P Tew; Molly Hardt; Supriya Gupta Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Ajeet Gajra; Stuart M Lichtman; Rupal Ramani; Vani Katheria; Laura Zavala; Arti Hurria Journal: Psychooncology Date: 2014-08-06 Impact factor: 3.894